PATENT CLAIM ANALYSIS

Application Number: 16098683
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-05
Patent Classification: ["549", "274000"]

Abstract:
The present invention relates to Chemistry, Pharmaceutical and in particular to the preparation of formulations from derivatives of phenolic or polyphenolic compounds and from derivatives of phenolic or polyphenolic compounds combined with tricyclic systems of the benzodiazepine type fused to derivatives of 1,4-dihydropyridines with action on the Central Nervous and Vascular Systems. These pharmaceutical compositions exhibit GABAergic, antiglutamatergic, calcium channel modulating, mitoprotective, anti-oxidant, anti-inflammatory, and antiapoptotic action, usable in the treatment of cardiovascular, cerebrovascular, neurodegenerative, neuropsychiatric and neurological diseases.

Claim (Index 15):
The method according to  claim 13 , wherein the dementia is vascular dementia.

Metadata:
- Claim Count in Document: 35.0
- Percentile: 98.0
- Lexical Diversity: 1.61404
- Patent Class: 549.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['10541082', '14912069', '14366901', '15996937', '12597956']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7052485694828113
- 35 USC 102 Novelty (BERT): 0.4839984589162933
- Combined Prediction Score: 0.6831235584261596
- Mean Citation Score: 147.57709599999995
- Max Citation Score: 153.19495
- Similarity Product: 102.80017643240392

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test